As the aforementioned involvement of JNK/Sab signaling in mitochondrial dysfunction of hepatocytes, we consider that scoparone could ameliorate the lipotoxic liver injury in NASH partially via inhibiting the JNK/Sab pathway and improving mitochondrial dysfunction (Figure 9). Here, SH3BP5 is linked to metabolic dysfunction-associated steatohepatitis.